Seven domestic and overseas companies have joined iCarbonX's Digital Life Alliance, with the aim of deepening people's understanding of their health and enabling them to lead healthier lives with the help of advanced technology.
PatientsLikeMe has spent the past 13 years building a vast online network of patients with chronic diseases—more than 500,000 people with over 2,700 conditions—who share experiences and health information with each other and with healthcare professionals.
Digital Life Alliance, a consortium of enterprises applying advanced technologies to health and medicine that plans to offer personalized solutions, is expanding to 7 members, as well as iCarbonX, the company that founded the network.
PatientsLikeMe, a social networking site that allows people with similar medical conditions to share experiences and symptoms, said Thursday that it’s received an investment of more than $100 million — its largest ever — from a Chinese genomicist and entrepreneur.
Online network PatientsLikeMe, which serves as an information, support and study recruitment source for people living with chronic conditions, has secured $100 million in new funding, largely from a new partnership with health data and genomics company iCarbonX. Existing investor Invus also contributed to the funding round, which is still open.
The Editorial in your September issue, entitled “Off the grid,” highlighted the risks of direct-to-consumer stem cell clinics and attempts by the US Food and Drug Administration (FDA; Rockville, MD) to enhance oversight of the sector1.
PatientsLikeMe revealed results from the first large-scale poll to assess patient priorities for the health care law. The poll’s 2,197 respondents are among the estimated 133 million Americans living with chronic conditions.
PatientsLikeMe co-founders Jamie and Ben Heywood were awarded the prestigious 2016 Humanitarian Award by the International Alliance of ALS/MND Associations. The Humanitarian Award is awarded to those whose work is of international significance for people affected by ALS/MND.
Nature features PatientsLikeMe and a PatientsLikeMe member in a piece focused on precision medicine
The Wall Street Journal features PatientsLikeMe’s virtual trial with Duke ALS Clinic